| Brain tumour cells interconnect to a functional and resistant network M Osswald, E Jung, F Sahm, G Solecki, V Venkataramani, J Blaes, S Weil, ... Nature 528 (7580), 93-98, 2015 | 924 | 2015 |
| CAR T cells in solid tumors: challenges and opportunities F Marofi, R Motavalli, VA Safonov, L Thangavelu, AV Yumashev, ... Stem cell research & therapy 12, 1-16, 2021 | 448 | 2021 |
| Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol P Nakhaei, R Margiana, DO Bokov, WK Abdelbasset, MAJ Kouhbanani, ... Frontiers in bioengineering and biotechnology 9, 2021 | 352 | 2021 |
| Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders A Markov, L Thangavelu, S Aravindhan, AO Zekiy, M Jarahian, ... Stem cell research & therapy 12, 1-30, 2021 | 330 | 2021 |
| A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine S Moghadasi, M Elveny, HS Rahman, W Suksatan, AT Jalil, ... Journal of translational medicine 19, 1-21, 2021 | 237 | 2021 |
| Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase M Jarahian, C Watzl, P Fournier, A Arnold, D Djandji, S Zahedi, ... Journal of virology 83 (16), 8108-8121, 2009 | 217 | 2009 |
| CAR‐NK cell in cancer immunotherapy; A promising frontier F Marofi, OF Abdul‐Rasheed, HS Rahman, HS Budi, AT Jalil, ... Cancer Science 112 (9), 3427-3436, 2021 | 193 | 2021 |
| Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients F Marofi, HS Rahman, ZMJ Al-Obaidi, AT Jalil, WK Abdelbasset, ... Stem Cell Research & Therapy 12, 1-23, 2021 | 178 | 2021 |
| Modulation of NKp30-and NKp46-mediated natural killer cell responses by poxviral hemagglutinin M Jarahian, M Fiedler, A Cohnen, D Djandji, GJ Hämmerling, C Gati, ... PLoS pathogens 7 (8), e1002195, 2011 | 152 | 2011 |
| Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44 A Byrd, SC Hoffmann, M Jarahian, F Momburg, C Watzl PloS one 2 (12), e1339, 2007 | 138 | 2007 |
| Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities A Hassanzadeh, HS Rahman, A Markov, JJ Endjun, AO Zekiy, ... Stem cell research & therapy 12 (1), 297, 2021 | 92 | 2021 |
| CAR-NK cell: a new paradigm in tumor immunotherapy F Marofi, AS Al-Awad, HS Rahman, A Markov, WK Abdelbasset, YI Enina, ... Frontiers in oncology 11, 2021 | 84 | 2021 |
| Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool O Hershkovitz, M Jarahian, A Zilka, A Bar-Ilan, G Landau, S Jivov, ... Glycobiology 18 (1), 28-41, 2008 | 76 | 2008 |
| The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment F Fan, MH Bashari, E Morelli, G Tonon, S Malvestiti, S Vallet, M Jarahian, ... Leukemia 31 (7), 1570-1581, 2017 | 73 | 2017 |
| Blockade of natural killer cell‐mediated lysis by NCAM140 expressed on tumor cells M Jarahian, C Watzl, Y Issa, P Altevogt, F Momburg International journal of cancer 120 (12), 2625-2634, 2007 | 54 | 2007 |
| A deep insight into CAR-T cell therapy in non-Hodgkin lymphoma: application, opportunities, and future directions F Marofi, HS Rahman, MH Achmad, KN Sergeevna, W Suksatan, ... Frontiers in immunology 12, 2021 | 41 | 2021 |
| Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy F Marofi, HS Rahman, L Thangavelu, A Dorofeev, F Bayas-Morejón, ... Stem cell research & therapy 12, 1-21, 2021 | 31 | 2021 |
| Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges E Razeghian, W Suksatan, HS Rahman, DO Bokov, WK Abdelbasset, ... Frontiers in immunology 12, 2021 | 30 | 2021 |
| Mesenchymal stem/stromal cells as a vehicle for cytokine delivery: an emerging approach for tumor immunotherapy E Razeghian, R Margiana, S Chupradit, DO Bokov, WK Abdelbasset, ... Frontiers in medicine 8, 2021 | 29 | 2021 |
| The CCR5 antagonist maraviroc causes remission of pancreatic cancer liver metastasis in nude rats based on cell cycle inhibition and apoptosis induction H Huang, M Zepp, RB Georges, M Jarahian, M Kazemi, E Eyol, ... Cancer Letters 474, 82-93, 2020 | 29 | 2020 |
